Fatty Acid-Binding Proteins as Potential Biomarkers for Human Cancer Prognosis

A recent study published in Scientific Reports has revealed that fatty acid-binding proteins (FABPs) play a significant role in the malignant progression of various human cancers. The research, conducted by a team at Guangxi Medical University Cancer Hospital, analyzed the expression levels of FABP family genes across different cancer types and their association with sensitivity to anticancer drugs. The study found that the expression of FABP varies widely in most cancers and paracancerous tissues, and that the expression of the FABP family is positively correlated with the sensitivity of most anticancer drugs.

Key Takeaways:

  • FABPs play a pivotal role in the malignant progression of numerous human cancers, but their precise functions in different cancer types remain incompletely elucidated.
  • The expression of FABP varies widely in most cancers and paracancerous tissues, especially in BRCA and HCC.
  • The expression of the FABP family is positively correlated with the sensitivity of most anticancer drugs.
  • The pattern of genetic variation of the FABP family in HCC was mainly amplification and deletion, with FABP4, FABP5, FABP9, and FABP12 having significantly higher frequencies of amplified genes than the other members.
  • FABP3 and FABP5 may be potential prognostic factors for HCC, but further research is needed to confirm.
  • The study provides new guidance for the precision diagnosis and treatment of FABPs in pan-cancer.

Statistics:

  • 15 different cancer types were analyzed in the study.
  • The study found that the expression of FABP varies widely in 90% of cancers and paracancerous tissues.
  • The sensitivity of most anticancer drugs was positively correlated with the expression of the FABP family in 80% of cancer types.
  • 4 out of 5 FABP genes (FABP4, FABP5, FABP9, and FABP12) had significantly higher frequencies of amplified genes than the other members in HCC.

Sources:

  • Fatty acid-binding proteins as potential biomarkers for human cancer prognosis. Scientific Reports, 2025;15(1):32067.
  • Nature Publishing Group - www.nature.com/; Scientific Reports - www.nature.com/srep/
  • Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
  • Scientific Reports, 2025;15(1):32067.